IntraGel Therapeutics

IntraGel Therapeutics Overview

INTRAGEL is a research-driven company dedicated to pioneering an advanced treatment for solid tumors using our state-of-the-art gel-based drug delivery technology. The SRGel platform enables local and prolonged release of a wide range of anti-cancer medications offering new life-changing cancer treatment options. The SRGel platform is revolutionizing cancer treatment by enabling local sustained release of anticancer drugs at the tumor site, to maximize therapeutic effectiveness while minimizing systemic exposure and adverse effects. Built on natural and safe fatty acids, its unique hydrophobic, biocompatible and biodegradable gel-based composition is a true breakthrough in drug delivery. As an injectable pre-filled single syringe, SRGel is easy to use, ready to be placed in any solid tumor, including surgically inaccessible tumors and/or chemo/radio-resistant tumors. SRGel has successfully been combined with cisplatin, its flagship product, TumoCure, to treat head and neck, and lung cancer. Other drugs, such as paclitaxel and temozolamide, have also been successfully combined to treat other tumors. Future products in development aim to address other unmet medical needs in, colorectal, ovarian, and testicular cancer.

Cumulative Funding Raised Over Time ($)

Latest News

Aug 2, 2023 · www.calcalistech.com

growth-positive

Intragel hopes to treat the 10% of inoperable cancer patients | CTech

Intragel Therapeutics, a pharmaceutical company, has raised a total of $2 million for its first product, TumoCure, designed to treat solid tumors. The company is currently raising an additional $5 million to get FDA-approved for a phase II clinical trial. Intragels product is based on a gel platform called SRGel, which is designed for sustained drug release and can replace multiple systemic treatments with a single application. The company is in advanced collaboration stages with leading global pharmaceutical companies, opening up possibilities for acquisition.

InvestmentExpand

Funding

Team Members

3

Employees: 1-10

Web & Social Links

Locations

Wadi el-Haj Street 13, Nazareth, Israel

Photos & Videos

1 item(s)

IntraGel Therapeutics Internal

Recent Updates

No update log entries.

Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.

Admin Info